Clinical Trials Browser

Ganglioneuroblastoma × Hematopoietic Stem Cell Transplantation × 90 days × Clear all

NCT06172296 2026-06-03

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Phase 3 Recruiting

Neuroblastoma, Ganglioneuroblastoma